2017 Speakers

Speakers Line-Up

Keynote Speaker

John Wilbanks
Chief Commons Officer, Sage Bionetworks, Senior Fellow,
Ewing Marion Kauffman Foundation and FasterCures, USA
TEDGlobal 2012 Speaker on “Let’s Pool Our Medical Data”

Speakers Line-up
Li Ling Liu, Director
Good Registration Management (GRM)Researcher, Deputy Director General Office, Taiwan Food and Drug Administration (TFDA), Taiwan

Eva Kopecna
Senior Director Generics Regulatory Affairs Global OTC
Teva Pharmaceuticals International GmbH, Switzerland  

Qing Xi
Head of Government Affairs, Market Access & Communications
Pfizer, China
Jean-François Baladi
Senior Executive, Health Economics and Market Access
Novartis Pharma K.K., Japan
Anh Bourcet
Associate Director, ASPAC Health Economic & Market Access, Orthopedics
Johnson & Johnson, Singapore

Rosalina Saleh
Market Access Lead
PT Boehringer Ingelheim Indonesia

Enrique A. Tayag
Assistant Secretary, Office for Policy and Health Systems
Department of Health, Philippines
Megan Kim
Head of Market Access Korea
Boehringer Ingelheim Pte Ltd, Korea
Nathan Kothandaraman
Lead, Market Access
Johnson & Johnson Sdn Bhd, Malaysia

Chris King
Real-World Insights Principal
QuintilesIMS, Singapore

Sittipong Liamsuwan
Policy & Market Access Director
MSD (Thailand) Ltd., Thailand
Colette Hamilton
Chief Operating Officer
RWE Genesys, United Kingdom

Tay Salimullah
Global Strategic Projects Leader, Real World Evidence
Novartis Pharma AG, Switzerland

Farida Malawi
Head of Public Sales and New Channels, Vaccine Policy & Advocacy and Market Access
Sanofi Pasteur, Indonesia
Michael Hofer
Regional Business Development Manager
DKSH, Asia
Neal Somchand
Senior Consultant
Deallus Consulting, Japan
Yi-Chieh Lin
Officer
Medical Review and Pharmaceutical Benefits Division, National Health Insurance Administration, Ministry of Health and Welfare, Taiwan

Robert Kraal
Chief Operations Officer
myTomorrows, Netherlands

Joseph Saba
Chief Executive Officer
Axios International

Maryline Marquet
APAC Managing Director
Human Care Systems (HCS)

Cameron Milliner
Head Public Affairs and Patient Advocacy - APAC
Shire, Singapore

Speakers Profile

Keynote Speaker

John Wilbanks
Chief Commons Officer, Sage Bionetworks, Senior Fellow, Ewing Marion Kauffman Foundation and FasterCures, USA
TEDGlobal 2012 Speaker on “Let’s Pool Our Medical Data” 

John Wilbanks seeks to transform and innovate medical research by accelerating data sharing between clinical studies. As the Chief Commons Officer at Sage Bionetworks, he is in-charge of figuring out how to design policies and technologies that allow health and biological data to be broadly share between patients, clinicians and data analysis.

Sage Bionetworks has put their open source toolkit innovation to the test by designing an application to conduct a set of Sage Bionetworks mobile research studies enrolling more than 100,000 participants in less than two years and integrated into more than 25 studies outside of Sage, including the US Precision Medicine Initiative

To view John’s talk at TEDGlobal 2012, click   https://www.ted.com/talks/john_wilbanks_let_s_pool_our_medical_data

Speakers Line-up

Qing Xi
Head of Government Affairs, Market Access & Communications
Pfizer, China

As the Senior Director of Government Affairs, Market Access & Communications of Pfizer China, Mr. XI is responsible for central and local government affairs, market access, policy advocacy, CSR, communications and media relations to support all business and function in China. As a member of Pfizer China Leadership Team, he reports to Regional President of Pfizer China directly.

From Oct. 2009 to Feb. 2016, Mr. XI was the Head of Communications in Pfizer China, leading Communications to develop and implement communication strategies and projects.

Before Pfizer acquired Wyeth in 2009, Mr. Xi was the Public Relation Director of Wyeth China. And before joining Wyeth in 2004, he had been working at Intel China for above 7 years in Public Relation & External Affairs.

He is now co-chairing the Communication Working Group of R&D Based Pharmaceutical Association Committee (RDPAC).

Mr. Xi got his EMBA degree from Shanghai Europe International Business School (CEIBS) and the Bachelor Degree from Shanghai Jiao-Tong University.


Jean-François Baladi
Senior Executive, Health Economics and Market Access
Novartis Pharma K.K., Japan

Jean-Francois Baladi is currently the senior executive, HealthEconomics and Market Access at Novartis Pharma K.K. (Japan). In this role, he oversees the pricing, market access and health economics and outcome research areas. Previously, Jean-Francois was the global head of health economics and market access for Novartis Oncology for 10 years, role in which he established and then led the function whose role was the determination of the global pricing and market access strategy for Novartis Oncology products as well as the health economics strategy and execution. Earlier in his career, Jean -Francois was Director of Healthcare Policy and Pharmacoeconomics at Novartis Canada. He had started his career in health economics as a research associate at the Canadian Coordinating Office for Technology Assessment. Jean-Francois holds an MBA from Concordia University in Montreal (Canada). He authored a number of peer-reviewed publications on pharmacoeconomics guidelines, Quality of life research, patient reported outcomes and various economic evaluations of pharmaceutical products.


Anh Bourcet
Associate Director, ASPAC Health Economic & Market Access, Orthopedics
Johnson & Johnson, Singapore

Anh is currently Regional Lead Global Orthopedics, Health Economics & Market Access in Johnson & Johnson Medical Asia-Pacific.
She first joined Janssen France in Medical Affairs, Immunology /CNS. Then, she worked for the French Health Safety Agency on innovative Medical Devices. Her report and recommendations on the regulatory framework paved the way for the European Commission to build their guidelines for Innovations containing nanomaterials.  She returned to Janssen Medical Affairs Asia-Pacific, Immunology, when moving back to Asia. End 2015, she transitioned to the Medical Device sector and to Health Economics & Market Access function. In her current role as Asia-Pacific Lead for Orthopedics, Anh has been driving regional Market Access and Evidence Generation Strategies to demonstrate the value of J&J products in the region, for optimal market access & reimbursement. 

Anh holds a PhD cum laude in Medicinal Chemistry from Paris VI & “Chimie ParisTech” Universities (France), and an Executive Master in Health Industry Management, ESSEC Business School (France).
With about 10 years of experience in healthcare, Anh is passionate about patient outcomes, education and new technology solutions to improve patient care.


Megan Kim
Head of Market Access Korea
Boehringer Ingelheim Pte Ltd, Korea

Megan started her career in the regulatory affairs area and served for license in and out, business development, marketing and business strategies as well as Market Access in Pharma industry for more than 25years. She has worked for Bayer Korea as BD director, Head of Marketing and Commercial in Pierre Fabre Medicament in Korea, then for Boehringer Ingelheim Korea as Head of BD and Market Access from 2009 thru 2014. She relocated to the BI Regional office in Singapore as Head of Market Access responsible for the area of Southeast Asia and Korea from 2014 thru 2016.  She returned back to Korea office and currently positioned as Head of Market Access Beohringer Ingelheim Korea.

Megan Kim majored in pharmacy at ChungAng University in Korea and received the master’s degree in Finance at Korea University and then, an MBA at the Booth School of Business, the University of Chicago.


Nathan Kothandaraman
Lead, Market Access
Johnson & Johnson Sdn Bhd, Malaysia

Nathan is the current Lead of Market Access at Johnson & Johnson Malaysia. He has over 20 years of wide ranging experience in the Healthcare and Pharmaceutical field as a pharmacist in the government hospital, pharmaceutical manufacturing, community pharmacy and pharmaceutical industry. He won a regional merit award for best regional marketing program in 2004 and global merit award for astounding strategic leadership for the launch of a new novel antipsychotic in 2006.  He has successfully participated and completed up to 24 various courses on leadership, process excellence and marketing excellence in addition to numerous local and international scientific conferences participation. He has a certificate in good clinical practice (GCP) and has been involved extensively in coordinating various clinical trials.

Nathan currently has responsibilities for market access and government affairs in policy engagement and facilitating access for various therapeutic categories.  He also has obtained course certificates in Health Economics and Health Technology Assessment.


Sittipong Liamsuwan
Policy & Market Access Director
MSD (Thailand) Ltd., Thailand

Sittipong Liamsuwan has over 15 years in Market Access covering i) Pricing & Reimbursement, ii) Health Economics & Outcome Research, and iii) Top Policy Key Stakeholder Management to define access strategy for patients.

Sittipong has educational background in Pharmaceutical, Political Sciences and Bioengineering as well as professional certifications in Business Intelligent & Research and Market Research

Sittipong has contributed to several multinational pharmaceutical companies and have improved access for patients in several Therapeutic Areas including CVD/ Bone/ Oncology/ Vaccine. He also has initiated access strategy and implementation in deep drive from national to community level

In additional to contributions in the country, Sittipong has held a regional role experience to develop Market Access Training (internal training on Market Access) program and Pricing and reimbursement database and information for Asia Pacific countries.


Tay Salimullah
Global Strategic Projects Leader, Real World Evidence
Novartis Pharma AG, Switzerland

Tay is Director Global Pricing and Market Access in Cell and Gene Therapies at Novartis Pharma Switzerland. Responsible for developing the market access strategy; value story; and pricing strategy across multiple indications for one-time potentially curative therapies for patients with relapsed refractory forms of hematological cancers.

Tay recently lead project HARMONY: an external industry leading public-private-partnership to shape outcomes, reimbursement and policy in Europe. HARMONY is the largest big data for better outcomes funded (€40M) programme. The project aims to foster better access and care for patients with various Hematological Malignancies with the use of big data as well as drive R&D efficiency.

Tay joined Novartis in 2013 as Market Access Director Region Europe in General Medicines. Prior to joining Novartis Tay worked at Pfizer for 11 years where he held several positions of increasing responsibilities within commercial, market access and strategy development. In 2009 Tay completed his Global Health Fellowship: in-field healthcare systems experience (USAID) in Malawi to scale eHealth organization to provide HIV solutions for 10% of the population. He has also worked in Asia as market access consultant and for a multibillion dollar private investment group to provide solutions for the low-middle income healthcare consumers across Asia.


Chris King
Real-World Insights Principal
QuantilesIMS, Singapore

As the Principal of Real-World Insights Solutions in APAC at QuintilesIMS, Chris King is leading the direction of next generation RWE offerings and services in the region. He is also the region’s therapeutic expert for oncology related consulting engagements.

Mr King has more than 15 years of extensive experience, and achievements in life science consulting. Prior to joining QuintilesIMS, Chris King was directly responsible for product development, team leadership, and client servicing for IPSOS’s European Oncology Monitor. At Datamonitor’s Healthcare consulting firm, he worked on various global pharmaceutical and biotech consultancy jobs in both global and emerging markets to support the successful launch of new products.

He holds a Bachelor of Arts from the University of British Columbia and an MBA from the London Business School.


Michael Hofer
Regional Business Development Manager
DKSH, Asia

Michael is Senior Manager in the Regional Business Development Team of DKSH Business Unit Healthcare. He is responsible for the expansion and innovation of new services as well as developing the business for Value Added Services (VAS) from Market Entry Solutions to Regulatory, Telemarketing & Patient Solutions across Asia. Michael has worked with DKSH since 2007 in various management functions in the areas of Business Development, Marketing, Communications and Branding. He is based in Bangkok, Thailand. Michael Hofer holds a M.A. degree from the University of Zurich in Media Science and Management & Economics.


Neal Somchand
Senior Consultant
Deallus Consulting, Japan

Neal is a Principal in the Deallus Tokyo office, joining Deallus in January 2016. Neal brings with him over 8 years of experience as a consultant for medical device and pharmaceutical companies.  Neal has managed projects across various geographies – concentrating on Japan and EU5 (UK, France, Germany, Spain, Italy) from a pricing and reimbursement perspective, monitoring the rapidly changing landscapes for client in addition to recommending optimal pricing strategies for new compunds .   

Prior to joining Deallus, Neal worked in London on pricing and market access assessments, delivering recommendations for EU launches.  He had a special interest in orphan drug pricing, and, in addition to EU-5, also worked on projects focused on Central Europe and Scandinavia.  Neal started his career at the Tokyo office of LEK as an Associate Consultant, focusing exclusively on the Japan market assessments and market entry strategy.
Neal holds a Masters in Oncology (with Distinction) from University of Nottingham, UK, and is a fluent speaker of Japanese and English.


Yi-Chieh Lin
Officer
Medical Review and Pharmaceutical Benefits Division, National Health Insurance Administration, Ministry of Health and Welfare, Taiwan

  • Associate Technical Specialist, Food and Drug Administration, Ministry of Health and Welfare, Taiwan, 2013-2015
  • Officer, Medical Review and Pharmaceutical Benefits Division, National Health Insurance Administration, Ministry of Health and Welfare, Taiwan, 2015-present

Colette Hamilton
Chief Operating Officer
RWE Genesys, United Kingdom

Colette is CEO of RWE Genesys, a provider of digitally enabled real world evidence solutions.  RWE Genesys is pioneering patient engagement to bring new insights to evidence based decision makers.   As a healthcare industry expert in health economics and outcomes research, Colette has in depth understanding of evidence requirements for patient access around the world.  Colette has a background in life science business development, health service management and healthcare consulting with one of the world’s big five accounting firms.  Colette has managed health economics and outcomes research projects in more than 26 countries.  She has an MBA in international healthcare policy and economics and an MSc in psychology.


Robert Kraal
Chief Operations Officer
myTomorrows, Netherlands

Robert Kraal, MSc, is the COO of myTomorrows, a company that supports physicians and their patients with unmet medical needs with access to pre-approval medicines globally.

Founded on the belief that technological advancements have the potential to radically change healthcare, myTomorrows’ programs are designed to streamline drug development timelines, provide better value to physicians, and facilitate tangible access to life-enhancing medicines.

For the past 20 years Robert has turned technology-driven companies from local start-ups to international best-in-class players. He is passionate about advancing internet-based business models to address a real customer need in complex networks of stakeholder involvement.


Joseph Saba
Chief Executive Officer
Axios International

Dr. Joseph Saba is Co-Founder and Chief Executive Officer of Axios International. Under his leadership, the company has developed several innovative healthcare access models for emerging markets and implemented access programs throughout Asia, the Middle East, Africa and Latin America. Dr. Saba is a French Lebanese medical doctor specialized in infectious disease, health management and statistics. He previously served in senior clinical research and development roles at the World Health Organization, UNAIDS and the Joint United Nations Program on HIV/AIDS. Dr. Saba holds a medical degree, along with a certificate of Medical Statistics, from the University Paris VI (France), is a graduate of St. Joseph University (Beirut, Lebanon), and holds a Master of Communications and Medical Management (MSc) from the Superior Business School (Paris, France). He has been featured in the Wall Street Journal, International Herald Tribune, Newsweek and Pharmaceutical Executive, among others.


Maryline Marquet
APAC Managing Director
Human Care Systems (HCS)

Maryline is APAC Managing Director of Human Care Systems (‘HCS’). Globally Since 2008, HCS designs and delivers technology driven therapy management to improve patient initiation, adherence, and persistence.

Prior to HCS Maryline was the head of Strategic Innovation at Becton Dickinson Asia, responsible for growing APAC region’s portfolio for new products and platforms. Prior to BD, she worked at International SOS Singapore where she was Global Director of Product Development and Marketing in Medical Supply Services.

Maryline relocated from Europe in 2015, where she had held a variety of positions in product marketing and project management at Janssen, Pharmaceutical Companies of Johnson and Johnson.  She designed, developed and delivered patient support programs (beyond the pill) in several therapeutic areas: oncology, infectious and metabolic diseases.

Maryline holds a Master of Science and Business from EDHEC and an MBA from INSEAD. Her early career was in consulting and start-up.


Rosalina Saleh
Market Access Lead
PT Boehringer Ingelheim Indonesia

Medical Doctor, 5 years experience as General Practitioner and Lecture, 17 years experienced in pharma industry in Indonesia (medical, sales and marketing). Working in both local and multinational pharma industries in Indonesia (Dexa Medica, Roche, BMS, GSK, Novartis). Currently work in Boehringer Ingelheim Indonesia as Market Access Lead.


Cameron Milliner
Head Public Affairs and Patient Advocacy - APAC
Shire, Singapore

With more than 15 years of experience within government, consultancy and multinational corporations, Cameron has a deep understanding of the development and implementation of public policy, stakeholder management and advocacy.

He currently works as the Head Public Affairs and Patient Advocacy for Shire, a biopharmaceutical company specialising in rare and specialty conditions, with responsibility for the Asia Pacific Region.  Prior to this, Cameron worked for a Pharmaceutical and Medical Device Company, as a Director of a Corporate Affairs consultancy and as a Senior Advisor to a Health Minister in an Australian State Government.

Cameron holds a Bachelor of Commerce (Marketing and Industrial Relations) from Griffith University and has been appointed a Visiting/Honorary Fellow of the Murdoch University School of Research and Innovation and the Centre for Comparative Genomics.  In addition to these roles he also holds an Honorary Fellowship of the McKell Institute, a public policy think tank specalising in social policy.


Farida Malawi
Head of Public Sales and New Channels, Vaccine Policy & Advocacy and Market Access
Sanofi Pasteur, Indonesia

Farida Malawi is a Sales, Qualified Quality Standard System and Assurance, Regulatory Affairs, Vaccine Public Policy and Government Affairs. She has vast experience that stretch for the past 16 years in Pharmaceutical business in Indonesia for different roles. She also has an extensive background in biotechnology, pharmaceutical and consumer industry businesses supported by project management, continuous improvement platform and leadership skills. She worked at Sanofi Indonesia for 3 years, the last position is Sales Head of Vaccine Division. She graduated as a Pharm.D and certified Pharmacist from University of Indonesia and was awarded Cum Laude in the Master of Business Administration with majority of Strategic Management from University of Gadjahmada. Farida likes to work in the area of market access and public health interface within the healthcare prevention initiatives.


Enrique A. Tayag
Assistant Secretary, Office for Policy and Health Systems
Department of Health, Philippines

Enrique A. Tayag is presently serving as Assistant Secretary for the Office for Policy and Health Systems, under the Department of Healt for Philippines. He provides overall-direction and oversight to the following Bureaus: Health Policy Development and Planning Bureau, Bureau of International Health Cooperation, Bureau of Local Health Systems Development and Health Human Resource Bureau, and the Pharmaceutical Division. He had previously served as Director in the Bureau of Local Health Systems Development and also the National Epidemiology Center.